Hexagon Nutrition IPO
Hexagon Nutrition is a health & wellness company making micronutrient premixes, clinical nutrition, and therapeutic nutrition products sold in over 75 countries.
IPO GMP
+₹4
+8.89% expected gain
Price Band
₹42 - ₹45
Lot Size
333 shares
Min Investment
₹14,985
Listing Date
June 12, 2026
About Hexagon Nutrition
Company overview, business, and key facts.
Hexagon Nutrition, established in 1993, manufactures health and wellness products across micronutrient premixes, clinical nutrition, and therapeutic nutrition. It operates facilities in India and Uzbekistan and serves customers in more than 75 countries.
Its consumer brands include Pentasure, Obesigo, Pediagold, and Nutrone, complemented by a B2B premix business and ESG-focused ready-to-use therapeutic foods.
Sector
Nutrition & Wellness
Founded
1993
Headquarters
Mumbai, Maharashtra
Employees
1,100+
Promoters
Subramaniam Ganapathy, Hexagon Holdings
Website
hexagonnutrition.com
IPO Details
Subscription Status
How many times each investor category has bid for the issue.
Strengths & Risks
Strengths
- Integrated Nutrition Solutions: The firm provides a one-stop solution for nutrition products from micromixes to therapies and clinical nutrition products. The diversified range of products helps the firm cater to nutrition needs of both business-to-business, consumer, and public health markets.
- In-house Brands for Wellness and Clinical Nutrition: The firm has built strong in-house brands like PENTASURE, OBESIGO, and PEDIAGOLD catering to various therapy areas like diabetes, renal, bariatric, and hepatic nutrition. The firm is present across 75+ countries around the world.
- Strong Research & Development and Innovation Capabilities: The company has two R&D centers that have a team of people who focus on formulation sciences, ingredient interactions, and sensory evaluations. These research & development capabilities allow the company to design nutrition products that do not affect taste, texture, and nutrients.
Risks
- Reconstruction of a portion of our Nashik Facility pursuant to past regulatory actions may lead to temporary production disruptions, operational inefficiencies, and potential revenue impact
- Quality and Compliance Risk: The selling of products that have passed their expiry date, are faulty, or do not meet compliance standards may expose the business to lawsuits and other negative repercussions on its functioning.
- Raw Material Availability and Pricing Risk: The company has to ensure that raw materials necessary for manufacturing are available at all times without any binding agreements with suppliers.
Financials
Restated summary financials for the most recent periods.
Figures are indicative and restated for presentation.
Hexagon Nutrition IPO Review
Analysis based on live GMP, subscription, and issue details.
As of today, Hexagon Nutrition IPO is trading at a grey market premium (GMP) of +₹4 (+8.89% estimated listing gain), indicating positive market sentiment.
The IPO has been subscribed 1.65x overall — QIB: 0.00x, NII: 2.03x, Retail: 2.43x.
Hexagon Nutrition IPO subscription has closed. The shares are expected to list on June 12, 2026.
The minimum investment required is ₹14,985 for 333 shares (1 lot). Retail investors can apply at cut-off price for the best chance of allotment.
Key strengths include: Integrated Nutrition Solutions: The firm provides a one-stop solution for nutrition products from micromixes to therapies and clinical nutrition products. The diversified range of products helps the firm cater to nutrition needs of both business-to-business, consumer, and public health markets.; In-house Brands for Wellness and Clinical Nutrition: The firm has built strong in-house brands like PENTASURE, OBESIGO, and PEDIAGOLD catering to various therapy areas like diabetes, renal, bariatric, and hepatic nutrition. The firm is present across 75+ countries around the world.. Investors should note the following risks: Reconstruction of a portion of our Nashik Facility pursuant to past regulatory actions may lead to temporary production disruptions, operational inefficiencies, and potential revenue impact; Quality and Compliance Risk: The selling of products that have passed their expiry date, are faulty, or do not meet compliance standards may expose the business to lawsuits and other negative repercussions on its functioning..
Disclaimer: IPO GMP is indicative and sourced from the grey market. This is not investment advice. Please consult a SEBI-registered advisor before investing.
Hexagon Nutrition IPO — Frequently Asked Questions
What is Hexagon Nutrition IPO GMP today?
Hexagon Nutrition IPO GMP (grey market premium) today is +₹4, suggesting an estimated listing gain of +8.89%. GMP is indicative and subject to change.
What is the price band of Hexagon Nutrition IPO?
The price band for Hexagon Nutrition IPO is ₹42 - ₹45 with a lot size of 333 shares. The minimum investment required is ₹14,985.
When is Hexagon Nutrition IPO allotment date?
Hexagon Nutrition IPO allotment is expected to be finalised on June 10, 2026. You can check your allotment status on the registrar's website (KFin Technologies Ltd) using your PAN number.
When will Hexagon Nutrition IPO list on NSE/BSE?
Hexagon Nutrition IPO is expected to list on BSE, NSE on June 12, 2026.
How to check Hexagon Nutrition IPO allotment status?
To check Hexagon Nutrition IPO allotment status, visit the registrar's website (KFin Technologies Ltd) and enter your PAN number, application number, or DP/Client ID. You can also check on the BSE IPO allotment page at https://www.bseindia.com/investors/appli_check.aspx.